glp 1 receptors in the brain GLP-1 mimetics and cognition A sympathetic brake on gut

Constipation is a common GLP-1 side effect

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care,Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity. Key Highlights: Digbi GLP-Fituses the science of precision biology to identify the best treatment path for obesity for an individual with 87% accuracy, which may include 1) only precision nutrition, 2) a combination of precision nutrition and lower-cost drugs like Metformin, or 3) a combination of precision nutrition and GLP-1 medications

be on it long-term

4 : Build governance and clinical review processes now in anticipation of potential future GLP-1 use in substance use disorder management.

Optimized for Akkermansia Growth: Akkermansia muciniphila is a beneficial bacterium known for its ability to strengthen the gut barrier and support a healthy microbiome

Inhibitors of DPP-4 participate in the pancreatic-endocrine-osseous axis by increasing endogenous GLP-1